Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
07 Setembro 2022 - 12:00PM
Press release – No. 4/
2022
Zealand Pharma
to Participate
in Morgan Stanley
20th Annual Global Healthcare
Conference
Copenhagen, DK and Boston, MA, September 7, 2022 – Zealand
Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078,) a
biotechnology company focused on the discovery and development of
innovative peptide-based medicines, today announced that the
company will participate in a fireside chat at the Morgan Stanley
20th Annual Global Healthcare Conference.
Morgan Stanley 20th
Annual Global Healthcare ConferenceDate:
Wednesday, September 14, 2022Presentation: 12:20 p.m. ET / 6:20
p.m. CET
A live webcast of the event will be available on the "Events
& Presentations" page in the Investor section of the Company's
website at https://www.zealandpharma.com/events-presentations. A
replay of the webcast will be archived on the Company's website
following the presentation.
# # #
About Zealand Pharma A/S Zealand Pharma A/S
(Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on
the discovery and development of peptide-based medicines. More than
10 drug candidates invented by Zealand have advanced into clinical
development, of which two have reached the market and three
candidates are in late-stage development. In addition, license
collaborations with Boehringer Ingelheim and AstraZeneca create
opportunities for more patients to potentially benefit from
Zealand-invented peptide investigational agents currently in
development.
Zealand was founded in 1998 and is headquartered in Copenhagen,
Denmark, with a presence in the U.S. that includes Boston. For more
information about Zealand’s business and activities, please visit
http://www.zealandpharma.com.
Contact:
Anna Krassowska, PhDVice President, Investor Relations &
Corporate CommunicationsZealand PharmaEmail:
ank@zealandpharma.com
David Rosen (U.S. Media)Argot PartnersEmail:
media@zealandpharma.com
Zealand Pharma AS (NASDAQ:ZEAL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Zealand Pharma AS (NASDAQ:ZEAL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Zealand Pharma AS da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de